Sprint Bioscience AB Market Cap

Sprint Bioscience AB has a market cap or net worth of 86.58 million as of September 12, 2024. Its market cap has increased by 4.20% in one year.

Market Cap

86.58M

Enterprise Value

50.57M

Revenue

86.21M

Ranking

n/a

PE Ratio

5.88

Stock Price

1.24

Market Cap Chart

Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 86.58M, an increase of 38.54%. That is a compound annual growth rate of 3.36%.

Market Cap History

Date	Market Cap	% Change
Sep 11, 2024	86.58M	-28.53%
Dec 29, 2023	121.14M	449.78%
Dec 30, 2022	22.03M	-88.47%
Dec 30, 2021	191.05M	17.26%
Dec 30, 2020	162.93M	8.20%
Dec 30, 2019	150.58M	-27.98%
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro
Dec 30, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca PLC	2,609.07B
Swedish Orphan Biovitrum AB (publ)	108.72B
Getinge AB (publ)	59.98B
Camurus AB (publ)	40.64B
Vitrolife AB (publ)	35.04B
Medicover AB (publ)	29.01B
Elekta AB (publ)	24.26B
Vimian Group AB (publ)	23.51B

Market Cap Rankings